If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCQS Natural Resources Regulatory News (CYN)

Robert Crayfourd and Keith Watson (Co-Fund Managers), CQS Natural Resources Growth and Income will be presenting and taking live Q&A at focusIR Investor Webinar on 14th May. Please register here.

Share Price Information for CQS Natural Resources (CYN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 191.00
Bid: 190.50
Ask: 192.50
Change: 1.00 (0.53%)
Spread: 2.00 (1.05%)
Open: 193.00
High: 193.00
Low: 191.00
Prev. Close: 190.00
CYN Live PriceLast checked at -
CQS Natural Resources Growth & Income is an Investment Trust

To provide shareholders with capital growth and income predominantly from a portfolio of mining and resource equities and of mining, resource and industrial fixed interest securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

28 Mar 2024 15:57

RNS Number : 7852I
CQS Natural Resources Grwth&Inc PLC
28 March 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0000353929

Issuer Name

CQS NATURAL RESOURCES GROWTH AND INCOME PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Saba Capital Management, L.P.

City of registered office (if applicable)

New York

Country of registered office (if applicable)

United States

4. Details of the shareholder

Name

City of registered office

Country of registered office

Saba Capital Master Fund, Ltd

Cayman Islands

Saba Capital R Fund, Ltd

Cayman Islands

Saba Capital Income & Opportunities Fund II

United States

Saba Capital CEF Special Opportunities Master Fund 2, Ltd

Cayman Islands

Saba Capital CEF Opportunities 1, Ltd

Cayman Islands

Saba Capital Income & Opportunities Fund

United States

Saba Capital Bluebird Fund, Ltd

Cayman Islands

Saba Capital Arcadia Master Fund, Ltd.

Cayman Islands

5. Date on which the threshold was crossed or reached

27-Mar-2024

6. Date on which Issuer notified

28-Mar-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

11.026900

11.026900

7375740

Position of previous notification (if applicable)

0.000000

10.014000

10.014000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

 

Sub Total 8.A

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Total Return Swap

08/17/2024

Cash

7375740

11.026900

Sub Total 8.B2

7375740

11.026900%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Boaz Weinstein

Saba Capital Management GP, LLC

Saba Capital Management GP, LLC

Saba Capital Management, LP

0.000000

11.026900

11.026900%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

28-Mar-2024

13. Place Of Completion

New York

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLBUGDXXUDDGSI
Date   Source Headline
10th Mar 20233:18 pmRNSNet Asset Value(s)
9th Mar 20232:44 pmRNSNet Asset Value(s)
8th Mar 20233:06 pmRNSNet Asset Value(s)
7th Mar 20232:27 pmRNSNet Asset Value(s)
6th Mar 20232:18 pmRNSNet Asset Value(s)
3rd Mar 20231:17 pmRNSNet Asset Value(s)
2nd Mar 20232:38 pmRNSNet Asset Value(s)
1st Mar 20232:18 pmRNSNet Asset Value(s)
28th Feb 202312:53 pmRNSNet Asset Value(s)
27th Feb 20233:03 pmRNSNet Asset Value(s)
24th Feb 20232:42 pmRNSNet Asset Value(s)
23rd Feb 202312:17 pmRNSNet Asset Value(s)
22nd Feb 20231:32 pmRNSNet Asset Value(s)
21st Feb 20231:43 pmRNSNet Asset Value(s)
20th Feb 20233:31 pmRNSNet Asset Value(s)
17th Feb 20233:21 pmRNSNet Asset Value(s)
16th Feb 20231:42 pmRNSNet Asset Value(s)
15th Feb 20232:26 pmRNSNet Asset Value(s)
14th Feb 20232:11 pmRNSNet Asset Value(s)
13th Feb 20233:47 pmRNSNet Asset Value(s)
10th Feb 20232:27 pmRNSNet Asset Value(s)
9th Feb 20231:02 pmRNSNet Asset Value(s)
8th Feb 20233:28 pmRNSNet Asset Value(s)
7th Feb 20234:08 pmRNSNet Asset Value(s)
6th Feb 20232:44 pmRNSNet Asset Value(s)
3rd Feb 20233:32 pmRNSNet Asset Value(s)
2nd Feb 20233:22 pmRNSNet Asset Value(s)
1st Feb 20232:35 pmRNSNet Asset Value(s)
31st Jan 20231:03 pmRNSNet Asset Value(s)
30th Jan 20233:03 pmRNSNet Asset Value(s)
27th Jan 20232:25 pmRNSNet Asset Value(s)
26th Jan 20232:04 pmRNSNet Asset Value(s)
25th Jan 20233:25 pmRNSNet Asset Value(s)
24th Jan 20231:25 pmRNSNet Asset Value(s)
23rd Jan 20231:34 pmRNSNet Asset Value(s)
20th Jan 20231:28 pmRNSNet Asset Value(s)
19th Jan 20233:17 pmRNSNet Asset Value(s)
18th Jan 20233:57 pmRNSNet Asset Value(s)
17th Jan 20231:59 pmRNSNet Asset Value(s)
16th Jan 20231:57 pmRNSNet Asset Value(s)
13th Jan 20231:22 pmRNSNet Asset Value(s)
12th Jan 20232:49 pmRNSNet Asset Value(s)
11th Jan 20234:03 pmRNSDividend Declaration
11th Jan 20233:57 pmRNSNet Asset Value(s)
10th Jan 20231:15 pmRNSNet Asset Value(s)
9th Jan 20233:33 pmRNSNet Asset Value(s)
6th Jan 202312:02 pmRNSNet Asset Value(s)
5th Jan 20233:45 pmRNSNet Asset Value(s)
4th Jan 20233:16 pmRNSNet Asset Value(s)
3rd Jan 20234:33 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.